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Abstract  
BACKGROUND: In the studies focusing on diabetic organisms, Streprozotocine (STZ) is a 
frequently used agent to induce diabetes in rats and mice. However the current studies do not 
represent practical importance of their statistical findings. For showing practical importance of the 
differences in plasma insulin levels of diabetic rats and mice induced by STZ, there should be a 
statistical synthesis regarding statistical findings of the studies.  
AIM: The purpose of this study is to make a meta-analysis of the studies on the effect of STZ on 
plasma insulin levels in diabetic rats and mice.  
MATERIALS AND METHODS: In this study 39 effect sizes (37 studies) about levels of plasma 
insulin were analyzed by calculating individual effect sizes (d) and mean effect size.  
RESULTS: The effect sizes were between -13.7 and +65.3 and the mean effect size value (+9.33) 
represented a large effect indicating that STZ was an effective agent to significantly decrease 
plasma insulin levels of diabetic rats and mice.  
CONCLUSION: It can be said that the differences in plasma insulin levels between STZ-applied 
and no application groups has a practical importance in making animal model of diabetes. 
 
 
 
 
 
 
 
Introduction 
 
Nowadays, diabetes is frequently seen in 
society, its prevalence is about 382 million people 
around the world [1]. Diabetes is characterized by 
insufficient secretion rate of insulin or lack of insulin 
activity [2, 3]. Diabetes is associated with different 
health problems including cardiovascular diseases, 
neuropathy, retinopathy, ulcers and amputations [4, 
5]. Treatment of diabetes is a complex issue but some 
animal models were developed to understand the 
management as diabetes is a chronic condition [6, 7]. 
Over 30 years, alloxan, streptozotocin (STZ, 2-deoxy-
2-(3-(methyl-3- nitrosoureido)-D-glucopyranose), high-
fat diet-fed and nicotinamid are used for establishing 
experimental diabetes models of animal [8].  
Streptozotocin is still commonly used agent to 
induce diabetes in rats and mice [9-12]. STZ is 
produced by Streptomycetes sachromogenes and 
STZ causes to abnormal B-cell functions by imparing 
glucose oxidatation and decreasing insulin 
biosynthesis and secretion [13, 14]. Szkudelski stated 
that STZ dose range is larger than alloxan and other 
agents and only one dose is enough to induce 
diabetes [15]. Decrease in plasma insulin levels in 
animal models after STZ application is used a sign for 
inducement of diabetes [16-18]. In spite of reporting 
significant differences in plasma insulin levels after 
STZ application, majority of the studies using STZ do 
not report practical importance or effect sizes of the 
differences. But there is a need to show practical 
importance for future decisions on dose and time of 
STZ application.  
Based on this idea, the purpose of this study 
is to make a meta-analysis of the studies on the effect 
of STZ on plasma insulin levels in diabetic organisms. 
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Materials and Methods 
 
In this study, meta-analysis approach was 
used to evaluate practical importance of the 
differences regarding plasma insulin levels of STZ-
induced diabetic rats and mice. Meta-analysis is 
different from a review including summarizing existent 
literature, since meta-analysis involves statistically 
synthesizing results of different studies [19, 20]. For 
meta-analysis in this study, Cohen’s d effect size 
values were calculated for 37 studies and mean effect 
size value was found for deciding about average 
effect size value as an indicator of mean practical 
importance of the differences in plasma insulin levels 
induced by STZ.  
Table 1: Descriptions of the publications in this study 
Publication 
Date 
Name of Journal or 
Institution 
Subject 
STZ Amount 
in the 
Application 
Time between STZ 
application and plasma 
insulin measurement 
2005 
Biochemical and 
Biophysical Research 
Communications 
Rats 65 mg/kg 9 days 
2005 Pharmacological Research Rats 50 mg/kg 4 weeks 
2005 
Journal of 
Ethnopharmacology 
Rats 65 mg/kg 15 days 
2005 
Journal of Biochemistry and 
Molecular Biology 
Rats 50 mg/kg 6 weeks 
2006 
Clinical and Experimental 
Pharmacology and 
Physiology 
Rats 55 mg/kg 21 days 
2006 Journal of Health Sciences Rats 55 mg/kg 30 days 
2006 
Molecular and Cellular 
Biochemistry 
Rats 100 mg/kg 45 days 
2006 
Basic & Clinical 
Pharmacology & Toxicology 
Rats 50 mg/kg 45 days 
2006 
Clinical and Experimental 
Pharmacology and 
Physiology 
Rats 55 mg/kg 30 days 
2006 Diabetes Mice 90-100 mg/kg 3 weeks 
2006 Phytotherapy Research Rats 50 mg/kg 21 weeks 
2007 
International Journal of 
Biological Macromolecules 
Rats 50 mg/kg 30 days 
2007 
Journal of 
Ethnopharmacology 
Rats 55 mg/kg 21 days 
2008 
Experimental Diabetes 
Research 
Rats 45 mg/kg 8 weeks 
2008 BMC Molecular Biology Rats 65 mg/kg 15 days 
2008 Atherosclerosis Rats 60 mg/kg 7 weeks 
2009 
Clinical and Experimental 
Ophthalmology 
Rats 60 mg/kg 1 week 
2010 Phytomedicine Rats 60 mg/kg 6 weeks 
2010 Pharmacognosy Res.  Rats 55 mg/kg 15 days 
2010 
Archives of Medical 
Research 
Rats 60 mg/kg 32 weeks 
2011 
Chemico-Biological 
Interactions 
Rats 50 mg/kg 7 days 
2012 
International Journal of 
Endocrinology 
Rats 65 mg/kg 5 days 
2012 
The Journal of 
Pharmacology And 
Experımental Therapeutıcs 
Rats 60 mg/kg 24 weeks 
2012 
West Virginia University, 
School of Medicine 
Mice 50 mg/kg 5 weeks 
2012 
Turkish Journal of Medical 
Sciences 
Rats 45 mg/kg 8 weeks 
2013 
BMC Complementary and 
Alternative Medicine 
Rats 
 
55 mg/kg 3 days 
2013 
Diabetology & Metabolic 
Syndrome 
Rats 50 mg/kg 60 days 
2014 
BMC Pharmacology and 
Toxicology 
Rats 50 mg/kg 1 week 
2014 Acta Histochemica Rats 40 mg/kg 72 hours 
2014 
European Journal of 
Pharmacology 
Rats 50 mg/kg 1 week 
2014 Phytomedicine Rats 40 mg/kg 4 weeks 
2014 Pain Medicine Rats 30 mg/kg 2 weeks 
2014 Pain Medicine Rats 35 mg/kg 2 weeks 
2014 Pain Medicine Rats 40 mg/kg 2 weeks 
2014 
Food and Chemical 
Toxicology 
Rats 40 mg/kg 28 days 
2015 
International Journal of 
Experimental Pathology 
Rats 45 mg/ kg 24 hours 
2015 Pharmacognosy Research Rats 90 mg/kg 10 weeks 
2015 Nutrition Rats 35 mg/kg 72 hours 
2015 Renal Failure Rats 60 mg/kg 5 weeks 
 
Selection of the Publications 
In selection process of the publications 
PubMed, Google Scholar, Proquest and National 
Theses Database System were searched by using 
key words “Plasma insulin levels, STZ, Rats”. The 
time restriction for the publications was 2005-2015. In 
National Theses Database System no thesis was 
found about the keywords it might be related to 
system error while Proquest search showed 89 
theses. However, one thesis was found appropriate. 
When Pubmed was searched 526 results were found. 
As the highest publication number, Google scholar 
search results gave 3960 publications.  
After adding the publications to the pool, 
checking abstracts and content of the publications 
were conducted. Eventually it was determined that 37 
studies reported change in plasma insulin levels of 
diabetic organisms and they reported 39 differences 
for effect size calculations across different doses of 
STZ. Descriptive knowledge about the publications is 
represented in Table 1. The titles of them can be seen 
in appendix (Table 3). 
 
Calculation of Effect Sizes and Analysis 
In this study plasma insulin levels measured 
in control and STZ groups were considered for 
calculating effect size values. The effect size of 
differences regarding plasma insulin levels were 
accepted as an indicator of practical importance of the 
differences, therefore one Cohen d formula was used 
to calculate effect sizes [21, 22].  
d= M1-M2 /√[σ1
2
+ σ2
2
 /2 ] for independent measures 
After individual effect sizes per difference in 
each publication were calculated, mean effect size 
value was obtained by adding all effect sizes and 
dividing total effect size score into number of 
individual effect sizes. Hence just only one value 
regarding effect of STZ on plasma insulin levels was 
gathered. 
 
 
Results 
 
Results of the study showed that only 4 of the 
all individual effect sizes indicated negative values 
while the rest of effect sizes (n=35) was positive. 
Moreover one small and 38 large effect sizes were 
seen in the calculations. Descriptive values regarding 
Plasma Insulin Levels in control and STZ-induced 
diabetes groups, Unit of Plasma Insulin Levels and 
Individual Effect Sizes were shown in Table 2. 
As seen in the Table 2, the individual effect 
sizes were between -13.7 to +65.3. The mean effect 
size value was found as +9.33.  
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Table 2: Descriptive Values regarding Plasma Insulin Levels, 
Unit of Plasma Insulin Levels and Individual Effect Sizes of the 
Differences in the Publications  
Publication 
Date 
Name of Journal or 
Institution 
Plasma 
Insulin Level 
in Control 
Group 
Plasma 
Insulin Level 
in STZ-
induced 
Diabetic 
Group 
Unit of 
Plasma 
Insulin 
Level 
Effect 
Size 
2005 
Biochemical and 
Biophysical Research 
Communications 
3.11 ± 0.67 0.34 ± 0.11 ng/ml 5.8 
2005 
Pharmacological 
Research 
57 ± 5 58 ± 4 mU/L 0.2 (-) 
2005 
Journal of 
Ethnopharmacology 
35.40 ± 2.17 6.75 ± 0.15 μU/mL 18.7 
2005 
Journal of Biochemistry 
and Molecular Biology 
3.2 ± 0.4 0.32 ± 0.1 ng/ml 10.2 
2006 
Clinical and 
Experimental 
Pharmacology and 
Physiology 
15.86 ± 1.38 5.12 ± 0.68 μU/mL 9.9 
2006 
Journal of Health 
Sciences 
16.54 ± 1.07 5.27 ± 0.76 μU/mL 12.2 
2006 
Molecular and Cellular 
Biochemistry 
13.67 ± 1.04 6.89 ± 0.22 μU/mL 9.1 
2006 
Basic & Clinical 
Pharmacology & 
Toxicology 
13.67± 1.04 6.89± 0.22 μU/mL 9.1 
2006 
Clinical and 
Experimental 
Pharmacology and 
Physiology 
16.6 ± 2.1 4.3 ± 1.3 μU/mL 7.1 
2006 Diabetes 0.90 ± 0.09 0.58 ± 0.09 ng/ml 3.5 
2006 Phytotherapy Research 2.49 ± 0.26 0.44 ± 0.0 ng/ml 14.6 
2007 
International Journal of 
Biological 
Macromolecules 
13.88 ± 14.52 4.87 ± 0.53 μU/mL 0.8 
2007 
Journal of 
Ethnopharmacology 
296.21 ± 
50.40 
69.89 ± 10.12 pM/L 6.2 
2008 
Experimental Diabetes 
Research 
11.8 ± 2.93 3.97 ± 0.86 mIU/L 3.64 
2008 BMC Molecular Biology 1.6 ± 0.3 0.7 ± 0.3 ng/ml 3 
2008 Atherosclerosis 1.82 ± 0.36 0.05 ± 0.03 μg/L 7.3 
2009 
Clinical and 
Experimental 
Ophthalmology 
2.23±0.18 0.99±0.31 ng/ml 4.96 
2010 Phytomedicine 38.6±3.8 8.2±1.4 μmol/mL 10.6 
2010 Pharmacognosy Res.  390.87 ± 1.18 420.25 ± 2.8 mg/dl 13.7 (-) 
2010 
Archives of Medical 
Research 
0.67±0.10 0.18 ±0.01 ng/ml 7 
2011 
Chemico-Biological 
Interactions 
16.55 ± 1.17 6.07 ± 0.99 μU/mL 9.7 
2012 
International Journal of 
Endocrinology 
38 ± 6 16 ± 2 μU/mL 4.9 
2012 
The Journal of 
Pharmacology And 
Experımental 
Therapeutıcs 
1.69 ± 0.09 0.29 ± 0.03 ng/dl 23 
2012 
West Virginia University, 
School of Medicine 
1.92±0.17 0.47±0.06 ng/ml 6.1 
2012 
Turkish Journal of 
Medical Sciences 
4.28 ± 0.83 0.12 ± 0.02 ng/ml 7.1 
2013 
BMC Complementary 
and Alternative Medicine 
14.2 ± 0.583 3.6 ± 0.509 μU/mL 19.6 
2013 
Diabetology & Metabolic 
Syndrome 
4.68± 0.84 0.65 ±0.14 μU/mL 6.7 
2014 
BMC Pharmacology and 
Toxicology 
0.31 ± 0.05 0.17 ± 0.04 ng/ml 2.8 
2014 Acta Histochemica 15.41 ± 1.21 8.37 ± 1.01 μU/mL 6.3 
2014 
European Journal of 
Pharmacology 
16.25±1.85 5.02±0.43 μU/mL 8.3 
2014 Phytomedicine 15.6 ± 0.5 6.3 ± 0.26 μIU/mL 23.8 
2014 Pain Medicine 4.26 ± 0.59 2.28 ± 0.32 μU/mL 4.3 
2014 Pain Medicine 4.26 ± 0.59 2.20 ± 0.30 μU/mL 4.5 
2014 Pain Medicine 4.26 ± 0.59 2.04 ± 0.42 μU/mL 4.4 
2014 
Food and Chemical 
Toxicology 
15.9 ± 1.3 26.1 ± 1.4 μU/mL 7.5 (-) 
2015 
International Journal of 
Experimental Pathology 
6.18± 0.01 0.95 ±0.12 ng/ml 65.3 
2015 
Pharmacognosy 
Research 
17.66± 2.91 83.33± 6.33 μU/mL 13.3 (-) 
2015 Nutrition 53.42±3.73 41.64±2.91 μU/mL 3.5 
2015 Renal Failure 8.40 ± 0.34 2.50 ± 0.38 ng/ml 16.8 
 
 
Discussion 
 
The results of this study made it clearer that 
STZ-application is an effective way of decreasing 
significantly plasma insulin levels of rats and mice. 
Mean effect size value calculated from the 
publications showed that practical importance of STZ-
induced decrease in plasma insulin levels had a large 
effect. In other words effect size value of +9.33 refers 
to a large effect size [23]. Therefore the mean value of 
the STZ applied group is over 90 percentile of the no 
treatment group or control group.  
The results of the study are in line with the 
findings of the current research studies using STZ for 
inducing diabetes in rats and mice [9, 10]. Sai Varsha, 
Thiagarajan, Manikandan and Dhanasekaran applied 
STZ (35mg/kg) to Male albino Wistar rats, the authors 
observed plasma insulin decrease in rats after 72 
hours [24].  
The findings of this study contribute to our 
understandings about practical importance of 
differences in plasma insulin levels induced by STZ. 
When looked at the number of the publications in this 
study, it can be seen that decisions are based on 
differences in the publications over 35. Hence the 
findings of this study make our inferences about 
plasma insulin level differences induced by STZ more 
valid rather than relying on only one study’s finding. At 
the same time findings of the study has a potential for 
informing researchers about dose and duration of STZ 
application to change plasma insulin levels of diabetic 
rats and mice. As another implication of this study, the 
publications analyzed in this study show 
characteristics of current practice about using STZ, 
therefore the effect sizes reported in this study also 
inform practice using STZ in diabetes studies.  
In spite of strong sides of this study, it can be 
suggested that number of the publications using STZ 
might be increased in future studies to improving 
quality of inferences and to make the analysis more 
comprehensive. At the same time, other publications 
involving reports and unpublished documents should 
also be investigated for determining effect sizes 
regarding the differences about plasma insulin levels 
induced by STZ. Finally future studies might look at 
the studies published before 2005. 
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Appendix 
Table 3: Titles of the publications 
Public
ation 
Date 
Titles of the publications 
2005 
Streptozotocin-induced diabetes in the rat is associated with enhanced tissue 
hydrogen sulfide biosynthesis 
2005 
Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced 
oxidative stress and -cell damage in rat pancreas 
2005 
Study of the hypoglycaemic activity of Lepidium sativum L. aqueous extract in 
normal and diabetic rats 
2005 
Red wine prevents brain oxidative stress and nephropathy in streptozotocin-
induced diabetic rats 
2006 
Beneficial effects of Aloe vera leaf gel extract on lıpıd profıle status in rats wıth 
streptozotocın diabetes 
2006 
Anti-diabetic activity of fruits of terminalia chebula on streptozotocin induced 
diabetic rats 
2006 Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues 
2006 
Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in 
streptozotocin-induced diabetic wistar rats 
2006 
Biochemical evaluation of antidiabetogenic properties of some commonly used 
Indian plants on streptozotocin-induced diabetes in experimental rats 
2006 
Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves 
pancreatic -cell mass and function in a rodent model of type 2 diabetes 
2006 
Effect of Japanese radish (Raphanus sativus) sprout (Kaiware-daikon) on 
carbohydrate and lipid metabolisms in normal and streptozotocin-induced diabetic 
rats 
2007 
Protective effect of Lycium barbarum polysaccharides on streptozotocin-induced 
oxidative stress in rats 
2007 
Effect of Sclerocarya birrea (Anacardiaceae) stem bark methylene 
chloride/methanol extract on streptozotocin-diabetic rats 
2008 
The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin 
Induced Type 2 Diabetes Rat Model 
2008 
Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, 
insulin receptor number and insulin activity in the kidney, liver and adipose tissue of 
streptozotocin-induced diabetic rats 
2008 
Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a 
rat model of streptozotocin-induced diabetes mellitus 
2009 
Effect of N-acetylcysteine on the early expression of inflammatory markers in the 
retina and plasma of diabetic rats 
2010 
Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose 
oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced 
diabetic Wistar rats 
2010 
Antihyperglycemic activity of Catharanthus roseus leaf powder in streptozotocin-
induced diabetic rats 
2010 
Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral 
Nerves in Streptozotocin-induced Diabetic Rats 
2011 
Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid 
isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats 
2012 
Intermittent Fasting Modulation of the Diabetic Syndrome in Streptozotocin-Injected 
Rats 
2012 
Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced 
Diabetic Rats 
2012 
Examination of novel cardiac mechanisms ınfluencing mitochondrial proteomes 
during diabetes mellitus 
2012 
Effects of lycopene on plasma glucose, insulin levels, oxidative stress, and body 
weights of streptozotocin-induced diabetic rats 
2013 
Anti-diabetic, anti-oxidant and anti-hyperlipidemic activities of Melastoma 
malabathricum Linn. leaves in streptozotocin induced diabetic rats 
2013 
The effect of a novel curcumin derivative on pancreatic islet regeneration in 
experimental type-1 diabetes in rats (long term study) 
2014 
CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin 
secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic 
patients 
2014 
β-Caryophyllene, a natural sesquiterpene, modulates carbohydrate metabolism in 
streptozotocin-induced diabetic rats 
2014 
Fisetin improves glucose homeostasis through the inhibition of gluconeogenic 
enzymes in hepatic tissues of streptozotocin induced diabetic rats 
2014 
Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells 
in streptozotocin (STZ)-induced diabetic rats 
2014 Establishment of a Rat Model of Type II Diabetic Neuropathic Pain 
2014 
Polyphenols-rich Cyamopsis tetragonoloba (L.) Taub. beans show hypoglycemic 
and β-cells protective effects in type 2 diabetic rats 
2015 
Effect of strawberry (Fragaria 3 ananassa) leaves extract on diabetic nephropathy 
in rats 
2015 
Anti-diabetic effects of ethanol extract of Bryonia laciniosa seeds and its saponins 
rich fraction in neonatally streptozotocin-induced diabetic rats 
2015 
Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free 
radical stress, as well as inhibiting NF-kB activation and iNOS expression in rat 
pancreas 
2015 
The effects of transdermal insulin treatment of streptozotocin-induced diabetic rats 
on kidney function and renal expression of glucose transporters 
 
 
